IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to 15 kb.

The first study participant was enrolled in July 2024, and since that time, the consortium has recruited over 300 ...

Research identifies MDGA2- BDNF/TrkB-dependent mechanism that may point to therapeutic approaches for autism spectrum disorder.

The discussion covered emerging biologics, AI applications, and a strategy for supporting biomanufacturing in the current political climate.

Ultima Genomics announces that it will provide three trillion DNA sequencing reads free of charge to researchers across the United States and Canada.

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Researchers say findings suggest it may be possible to stop cancer growth using approaches such as restraining TE activity in ...

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

Officials at ARM, ASGCT, and ISCT convened a small group of scientists, policy experts, religious leaders and patient ...